ProSomnus Delivers Record Q1 Performance
ProSomnus’ CEO says the record quarter reflects growing acceptance of its precision medical devices as a solution for sleep apnea treatment.
Read MoreProSomnus’ CEO says the record quarter reflects growing acceptance of its precision medical devices as a solution for sleep apnea treatment.
Read MoreThe new facility, built using a $5 million construction grant, will give investigators access to state-of-the-art technology to conduct innovative sleep and circadian rhythm research.
Read MoreThe companies detail how the new partnership, which combines Sunrise’s artificial intelligence solutions and the technologies of eXciteOSA, will improve patient care.
Read MoreThe research suggests close monitoring after a COVID-19 infection may help adults with sleep apnea.
Read MoreThe research suggests that many people with sleep apnea are not aware that their snoring and sleepiness are signs of a problem.
Read More